Interestingly, methylation of the RASSF1A CpG island may be correlated to melanoma development and progression as it has been reported that RASSF1A is less frequently methylated in early-stage melanoma but in 50% of stage III and IV melanoma samples [37], thus suggesting that this epigenetic change contributes to melanoma progression. Here, RASSF1 is linked to melanoma.